Piper Jaffray analyst Edward Tenthoff offered some positive comments on Idera Pharmaceuticals (NASDAQ: IDRA) ahead of American Society of Hematology ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE